Near-infrared spectroscopy-derived StO2 can predict mortality in circulatory shock, but high-quality data on the impact of NIRS monitoring are lacking.
Recently, the combination of increasing costs for the provisions of blood products1, increasing recognition of the risks associated with transfusion and growing awareness of the possible future shortage of blood supply has raised the interest of the scientific community in the concept of "blood management".